IMMEDIATE ZIDOVUDINE TREATMENT PROTECTS SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED NEWBORN MACAQUES AGAINST RAPID ONSET OF AIDS

被引：69

作者：

VANROMPAY, KKA ^{[1
]}

OTSYULA, MG ^{[1
]}

MARTHAS, ML ^{[1
]}

MILLER, CJ ^{[1
]}

MCCHESNEY, MB ^{[1
]}

PEDERSEN, NC ^{[1
]}

机构：

[1] UNIV CALIF DAVIS,SCH VET MED,DEPT MED & EPIDEMIOL,DAVIS,CA 95616

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1995年 / 39卷 / 01期

关键词：

D O I：

10.1128/AAC.39.1.125

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Simian immunodeficiency virus (SIV) infection of newborn rhesus macaques is a practical animal model of pediatric AIDS. Intravenous inoculation of rhesus newborns with uncloned SIVmax resulted in a high virus load, no antiviral immune responses, severe immunodeficiency, and a high mortality rate within 3 months. In contrast, immediate oral zidovudine (AZT) treatment of SIV-inoculated rhesus newborns either prevented infection or resulted in reduced virus load, enhanced antiviral immune responses, a low frequency of AZT-resistant virus isolates, and delayed disease progression with negligible toxicity. These results suggest that early chronic AZT treatment of human immunodeficiency virus-exposed newborns may have benefits that outweigh its potential side effects.

引用

页码：125 / 131

页数：7

共 43 条

[21] EARLY VIREMIA AND IMMUNE-RESPONSES IN VERTICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].

LUZURIAGA, K ;

MCQUILKEN, P ;

ALIMENTI, A ;

SOMASUNDARAN, M ;

HESSELTON, RA ;

SULLIVAN, JL .

JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (05) :1008-1013

[22] DEFICIENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC CYTOTOXIC-T CELL RESPONSES IN VERTICALLY INFECTED CHILDREN [J].

LUZURIAGA, K ;

KOUP, RA ;

PIKORA, CA ;

BRETTLER, DB ;

SULLIVAN, JL .

JOURNAL OF PEDIATRICS, 1991, 119 (02) :230-236

[23]

MARTHAS ML, UNPUB

[24] A MULTICENTER TRIAL OF ORAL ZIDOVUDINE IN CHILDREN WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE [J].

MCKINNEY, RE ;

MAHA, MA ;

CONNOR, EM ;

FEINBERG, J ;

SCOTT, GB ;

WULFSOHN, M ;

MCINTOSH, K ;

BORKOWSKY, W ;

MODLIN, JF ;

WEINTRUB, P ;

ODONNELL, K ;

GELBER, RD ;

ROGERS, GK ;

LEHRMAN, SN ;

WILFERT, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) :1018-1025

[25]

OCHS HD, 1991, J MED PRIMATOL, V20, P193

[26] THE PHARMACOKINETICS AND SAFETY OF ZIDOVUDINE IN THE 3RD TRIMESTER OF PREGNANCY FOR WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND THEIR INFANTS - PHASE-I ACQUIRED-IMMUNODEFICIENCY-SYNDROME CLINICAL-TRIALS GROUP-STUDY (PROTOCOL 082) [J].

OSULLIVAN, MJ ;

BOYER, PJJ ;

SCOTT, GB ;

PARKS, WP ;

WELLER, S ;

BLUM, MR ;

BALSLEY, J ;

BRYSON, YJ ;

BOND, B ;

EFANTISPOTTER, J ;

GILLESPIE, S ;

GOURLEY, J ;

HELFGOTT, A ;

LAI, S ;

MITCHELL, C ;

OROURKE, S ;

PARKS, W ;

PERRYMARX, D ;

SCOTT, W ;

SETTLAGE, R ;

STIEHM, R .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (05) :1510-1516

[27] USE OF ZIDOVUDINE FOLLOWING OCCUPATIONAL EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS [J].

PARA, MF .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (05) :884-885

[28] EFFECT OF CONTINUOUS INTRAVENOUS-INFUSION OF ZIDOVUDINE (AZT) IN CHILDREN WITH SYMPTOMATIC HIV INFECTION [J].

PIZZO, PA ;

EDDY, J ;

FALLOON, J ;

BALIS, FM ;

MURPHY, RF ;

MOSS, H ;

WOLTERS, P ;

BROUWERS, P ;

JAROSINSKI, P ;

RUBIN, M ;

BRODER, S ;

YARCHOAN, R ;

BRUNETTI, A ;

MAHA, M ;

NUSINOFFLEHRMAN, S ;

POPLACK, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (14) :889-896

[29] ONTOGENY OF ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ANTIBODY-PRODUCTION IN HIV-1-INFECTED INFANTS [J].

POLLACK, H ;

ZHAN, MX ;

ILMETMOORE, T ;

AJUANGSIMBIRI, K ;

KRASINSKI, K ;

BORKOWSKY, W .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2340-2344

[30]

REED L. J., 1938, AMER JOUR HYG, V27, P493

← 1 2 3 4 5 →